Lifecore Biomedical Inc. (LFCR) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Historical revenue and profitability trends for Lifecore Biomedical Inc.
The chart above illustrates Lifecore Biomedical Inc.'s revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Lifecore Biomedical Inc.'s business.
How efficiently Lifecore Biomedical Inc. converts revenue into profit
Profit margins reveal how much of each dollar of revenue Lifecore Biomedical Inc. retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Lifecore Biomedical Inc. to continue growing earnings in the coming year. The consensus analyst rating is 4.3333 based on 3 analysts.
Based on our comprehensive analysis, Lifecore Biomedical Inc. (LFCR) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Lifecore Biomedical Inc.'s historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Lifecore Biomedical Inc. stacks up against similar companies
Explore growth analysis for top stocks
Related: LFCR Valuation, LFCR Dividend, LFCR Financial Health
Compare: LFCR vs AAPL, LFCR vs MSFT, LFCR vs GOOGL